Evaluation of the influence of physical problems, emotional problems, and extent of disease on the distress level (DL) in breast cancer (BC) women
Univariate analysis
DOI:
10.1200/jco.2009.27.15_suppl.e20628
Publication Date:
2020-08-25T20:21:03Z
AUTHORS (6)
ABSTRACT
e20628 Background: Despite recent treatment advances, BC diagnosis is still synonymous to death, and suffering provides emotional impairment in most of patients. Thus the distress assessment management essential component comprehensive patient care.The aim study was recognize DL group patients (pts) at different stages disease period evaluate important causes sources. Methods: In 60 women (median age 58 years, range: 37–86) diagnosed within last two measurement level performed using Distress Thermometer scale with problem list attached, according NCCN practice quidelines recommendation for assessment. The median time from data collecting moment 3.9 months. Most pts were postmenopausal (70%), have positive family cancer history (60%) suffered other diseases (75%); 45% them presented stage III (stage I - 26%, II 23%, IV 5%). Chemotherapy received 55% pts, surgical 65% radiotherapy 46%. At evaluation 61% remained free symptoms 72% strong stressful event during year. Results: whole 5 (range 0–10) 76% 4 or higher. Problem-list revealed that 96% had physical, 90% emotional, 38% practical 20% problems. Both univariate multivariate analysis independent correlation for: physical problems (p=0.000009), peripheral blood granulocytes (p=0.000024), strong-stressful passed year (p=0.005) sadness (p=0.01) correlated negatively (p=0.008). Conclusions: has shown associated mostly practical, personal near past. surgery a source anti-distress. These indicate need not neglecting individual medical psychosocial each provide best psychological support, expecially who are qualified to, before surgery. No significant financial relationships disclose.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....